Last updated on November 2017

A Double-Blind, Randomized, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis


Brief description of study

A Double-Blind, Randomized, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis

Detailed Study Description

This is a study for a treatment to House Dust Mite Allergy.

Clinical Study Identifier: TX7260

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Ann Felder

Clinical Research Atlanta
Stockbridge, GA USA
  Connect »